Legacy Capital Group California’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,754
Closed -$237K – 314
2026
Q1
$237K Sell
2,754
-1,336
-33% -$120K 0.09% 260
2025
Q4
$357K Sell
4,090
-1,266
-24% -$96.1K 0.09% 268
2025
Q3
$307K Sell
5,356
-1,140
-18% -$65.6K 0.08% 288
2025
Q2
$383K Buy
6,496
+930
+17% +$60.1K 0.11% 220
2025
Q1
$407K Buy
5,566
+691
+14% +$57.1K 0.14% 188
2024
Q4
$403K Buy
4,875
+641
+15% +$50.6K 0.12% 205
2024
Q3
$303K Buy
4,234
+1,221
+41% +$86.2K 0.1% 229
2024
Q2
$206K Buy
+3,013
New +$180K 0.07% 288

Other funds holding GMED

Legacy Capital Group California's GMED Position: Q2 2026 in Review

Legacy Capital Group California sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 2,754 shares — an estimated $237K sold.

Legacy Capital Group California first reported a position in GMED in Q2 2024 and held it in 8 quarters. The position peaked at $407K in Q1 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Legacy Capital Group California reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Legacy Capital Group California sold 2,754 Globus Medical shares in Q2 2026, an estimated $237K.
  • Legacy Capital Group California first reported a position in Globus Medical in Q2 2024 and held it in 8 quarters.
  • Legacy Capital Group California's Globus Medical position peaked at $407K in Q1 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Legacy Capital Group California's 13F filing for Q2 2026, filed 29 Jul 2026.